Calcitonin gene-related peptide and migraine

Authors:
  • HDH Doods
    H Doods
  • SJS Just
    S Just
  • MSM Schindler
    M Schindler
  • WEW Eberlein
    W Eberlein
  • WEW Engel
    W Engel
  • KRK Rudolf
    K Rudolf
  • KAK Arndt
    K Arndt

Abstract
Although the so-called triptans are efficacious and are generally well-tolerated drugs for the treatment of migraine headache, there is still a need for improvement of migraine therapy. The relatively low number of patients becoming pain free in addition to the relatively high number of patients experiencing a recurrence of headache and lacking consistency of relief, together with the potential for cardio vascular adverse effects, reflect the limitations of the triptans as the present therapeutic standards. Since the introduction of triptans to the market, several other treatment approaches targeting different aspects of migraine pathogenesis have reached clinical status, but most of them failed or showed no real therapeutic advantage.